REVOLADE cpr pell 75 mg 28 pce

7680601220064 CH-60122 B02BX05 06.99.0.

Reimbursement limitations:

REVOLADE.01a

Pour le traitement de première intention de l’anémie aplasique sévère (AAS) acquise en association avec …

REVOLADE cpr pell 75 mg 28 pce
REVOLADE cpr pell 75 mg 28 pce
REVOLADE cpr pell 75 mg 28 pce
1 / 3
google

Details

Product number
6012206
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
eltrombopagum 75 mg ut eltrombopagum olaminum, mannitolum, cellulosum microcristallinum, povidonum K 30, carboxymethylamylum natricum A corresp. natrium 0.784-1.176 mg, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), E 172 (nigrum), pro compresso obducto.

Articles (1)

Revolade 75 mg, Filmtabletten
Filmtabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
01/02/2024
Professional SmPC
Français
01/02/2024
Professional SmPC
Italien
01/02/2024
Patient information leaflet
Allemand
04/02/2022
Patient information leaflet
Français
04/02/2022
Patient information leaflet
Italien
04/02/2022

Detailed composition

Substance Quantity Type Category
(N/A)
75.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 3272.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2018

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
60122
Drug name
Revolade, Filmtabletten
Galenic form
FILM
ATC Code
B02BX05
Authorization status
Z
Dispensation category
A
First authorization
23/06/2010
Authorization expiration date
31/12/9999
IT number
06.99.0.
Domain
Human medicine
Field of application
Zur Behandlung von erwachsenen Patienten mit (idiopathischen) immunthrombozytopenischen Purpura (ITP), die auf andere Therapieoptionen (z.B. Kortikosteroide, Immunglobuline oder Splenektomie) nicht genügend ansprachen, bei erhöhtem Blutungsrisiko infolge ausgeprägter Thrombozytopenie

Packaging details

Description (FR)
REVOLADE cpr pell 75 mg 28 pce
Description (DE)
REVOLADE Filmtabl 75 mg 28 Stk
Market launch
08/05/2018
Narcotic (BTM)
No

Other packaging sizes

REVOLADE cpr pell 25 mg 14 pce
14 TABL
View
REVOLADE cpr pell 25 mg 28 pce
28 TABL
View
REVOLADE cpr pell 50 mg 14 pce
14 TABL
View
REVOLADE cpr pell 50 mg 28 pce
28 TABL
View
REVOLADE cpr pell 12.5 mg 14 pce
14 TABL
View